Nektar Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.About NKTR
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit.
CEOHoward W. Robin
CEOHoward W. Robin
Employees61
Employees61
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded1990
Founded1990
Employees61
Employees61
NKTR Key Statistics
Market cap105.58M
Market cap105.58M
Price-Earnings ratio-0.89
Price-Earnings ratio-0.89
Dividend yield—
Dividend yield—
Average volume579.13K
Average volume579.13K
High today$8.86
High today$8.86
Low today$8.27
Low today$8.27
Open price$8.39
Open price$8.39
Volume371.25K
Volume371.25K
52 Week high$22.79
52 Week high$22.79
52 Week low$6.48
52 Week low$6.48
Analyst ratings
75%
of 8 ratingsBuy
75%
Hold
12.5%
Sell
12.5%
People also own
Based on the portfolios of people who own NKTR. This list is generated using Robinhood data, and it’s not a recommendation.